These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1241697)

  • 1. Proliferation of mouse ascites mammary carcinoma MM2 cells in the primary culture.
    Mori T; Takaoka T; Katsuta H
    Jpn J Exp Med; 1975 Apr; 45(2):123-31. PubMed ID: 1241697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascites mammary carcinoma MM2 cells of the mouse in tissue culture.
    Miyata M; Takaoka T; Katsuta H
    Jpn J Exp Med; 1969 Apr; 39(2):153-66. PubMed ID: 5308446
    [No Abstract]   [Full Text] [Related]  

  • 3. Fetal calf serum and epidermal growth factor prevent the inhibitory action of a chalone-like growth inhibitor for Ehrlich ascites mammary carcinoma cells in vitro.
    Lehmann W; Graetz H; Widmayer R; Langen P
    Biomed Biochim Acta; 1984; 43(7):971-4. PubMed ID: 6240265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction in culture between mouse ascites mammary carcinoma (MM2) cells and lymphoid cells of isologous mice.
    Katsuta H; Ashikawa K; Takaoka T
    Jpn J Exp Med; 1975 Jun; 45(3):223-9. PubMed ID: 1177362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of different mammary epithelial cell lines to a mammary derived growth inhibitor (MDGI).
    Lehmann W; Widmaier R; Langen P
    Biomed Biochim Acta; 1989; 48(1):143-51. PubMed ID: 2775246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of extracellular matrix on the growth and casein gene expression of primary mouse mammary tumor cells in vitro.
    Chou JL; Shen ZX; Stolfi RL; Martin DS; Waxman S
    Cancer Res; 1989 Oct; 49(19):5371-6. PubMed ID: 2766303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resorbing bone stimulates tumor cell growth. A role for the host microenvironment in bone metastasis.
    Manishen WJ; Sivananthan K; Orr FW
    Am J Pathol; 1986 Apr; 123(1):39-45. PubMed ID: 3457536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous cell loss during growth of postconfluent primary cultures from mammary adenocarcinomas.
    Hosick HL
    Cancer Res; 1976 Sep; 36(9 pt.1):3126-30. PubMed ID: 987849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved synthetic medium suitable for tissue culture of various mammalian cells.
    Takaoka T; Katsuta H
    Jpn J Exp Med; 1975 Feb; 45(1):11-7. PubMed ID: 1228224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture.
    Noguchi S; Nishizawa Y; Nakamura N; Uchida N; Yamaguchi K; Sato B; Kitamura Y; Matsumoto K
    Cancer Res; 1987 Jan; 47(1):263-8. PubMed ID: 3791211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anchorage-independent growth-conferring factor production by rat mammary tumor cells.
    Zwiebel JA; Davis MR; Kohn E; Salomon DS; Kidwell WR
    Cancer Res; 1982 Dec; 42(12):5117-25. PubMed ID: 6291748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen.
    van der Burg B; Rutteman GR; Blankenstein MA; de Laat SW; van Zoelen EJ
    J Cell Physiol; 1988 Jan; 134(1):101-8. PubMed ID: 3275677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro.
    Kittrell FS; Oborn CJ; Medina D
    Cancer Res; 1992 Apr; 52(7):1924-32. PubMed ID: 1372532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrition of mouse ascites tumor cells in primary culture. I. Large molecular substances and conditioned media.
    Morgan JF
    J Natl Cancer Inst; 1970 Mar; 44(3):623-31. PubMed ID: 11515431
    [No Abstract]   [Full Text] [Related]  

  • 16. Pregnancy-dependent to ovarian-independent progression in mammary tumors delineated in primary culture: changes in signal transduction, growth factor regulation, and matrix interaction.
    Imagawa W; Bandyopadhyay GK; Garcia M; Matsuzawa A; Nandi S
    Cancer Res; 1992 Dec; 52(23):6531-8. PubMed ID: 1330295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascites tumor fluid and bovine serum albumin as supplements in presomite mouse embryo cultures.
    Meneses JJ; Pedersen RA
    J Exp Zool; 1984 Sep; 231(3):355-62. PubMed ID: 6502087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-H-2 restriction specificity of tumor-regressor mouse sera with regard to their activity to inhibit tumor cell transplantation.
    Egawa K; Kiyohara T; Tanino T
    Jpn J Exp Med; 1982 Oct; 52(5):255-60. PubMed ID: 7169670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Had-1, a uridine 5'-diphosphogalactose transport-defective mutant of mouse mammary tumor cell FM3A: composition of glycolipids, cell growth inhibition by lactosylceramide, and loss of tumorigenicity.
    Taki T; Ogura K; Rokukawa C; Hara T; Kawakita M; Endo T; Kobata A; Handa S
    Cancer Res; 1991 Mar; 51(6):1701-7. PubMed ID: 1998961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.